Accessibility Menu
ClearPoint Neuro Stock Quote

ClearPoint Neuro (NASDAQ: CLPT)

$24.74
(-2.1%)
-0.53
Price as of October 24, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$24.74
Daily Change
(-2.1%) $0.53
Day's Range
$24.74 - $26.72
Previous Close
$24.74
Open
$25.93
Beta
1.78
Volume
599,288
Average Volume
814,293
Market Cap
703.3M
Market Cap / Employee
$24.74M
52wk Range
$9.76 - $30.10
Revenue
-
Gross Margin
0.60%
Dividend Yield
N/A
EPS
-$0.80
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

ClearPoint Neuro Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
CLPT+96.66%+241.71%+27.82%-18%
S&P+16.9%+95.99%+14.39%+416%

ClearPoint Neuro Company Info

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

Financial Health

General

Q2 2025YOY Change
Revenue$9.22M17.3%
Gross Profit$5.56M11.4%
Gross Margin60.29%-3.2%
Market Cap$337.48M128.3%
Market Cap / Employee$2.93M0.0%
Employees1157.5%
Net Income-$5.84M-32.4%
EBITDA-$5.05M-18.2%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$41.54M26.5%
Accounts Receivable$4.85M7.1%
Inventory6.3-21.6%

Liabilities

Q2 2025YOY Change
Long Term Debt$35.13M963.7%
Short Term Debt$0.33M-96.8%

Ratios

Q2 2025YOY Change
Return On Assets-38.50%-2.6%
Return On Invested Capital-42.81%2.7%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$2.64M0.9%
Operating Free Cash Flow-$2.55M4.3%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book10.6614.6312.9316.71291.19%
Price to Sales10.1613.5310.2210.0490.42%
Price to Tangible Book Value10.8914.9513.1817.11290.09%
Enterprise Value to EBITDA-62.31-79.53-55.01-65.56117.29%
Return on Equity-68.4%-81.2%-76.2%-85.7%41.85%
Total Debt$3.69M$3.57M$3.44M$35.46M156.98%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.